Inventor · disambiguated record
Lorna Duffy
Also filed as: DUFFY LORNA ANNE · Duffy Lorna
11 granted patents·9 pending applications·44 citations·filing 2013–2024
86Inventor score
Files withSTEP PHARMA S A S8CORCEPT THERAPEUTICS INC7HORIZON ORPHAN LLC2MITOKININ INC2RESPIVERT LTD1
Top patents by PatentIndex Score
20 records- 0192US9249125B2Pyrazole derivatives as p38 MAP inhibitorsRESPIVERT LTD·Filed 2013·Granted Feb 2, 2016·30 cites·12 claims
- 0291US11787780B2Quaternary indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·3 cites·28 claims
- 0386US11505547B2CompoundsSTEP PHARMA S A S·Filed 2018·Granted Nov 22, 2022·3 cites·20 claims
- 0483US11542238B2Pyrimidine cyclohexenyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jan 3, 2023·5 cites·32 claims
- 0582US10906904B2ADO-resistant cysteamine analogs and uses thereofHORIZON ORPHAN LLC·Filed 2016·Granted Feb 2, 2021·2 cites·4 claims
- 0678US2025214971A1Quaternary indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0777US12180186B2Quaternary indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·0 cites·21 claims
- 0874US2025115583A1Bicyclic indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0973US11655246B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2018·Granted May 23, 2023·1 cites·19 claims
- 1070US12098141B2Bicyclic indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·27 claims
- 1170US12018001B2Pyrimidine cyclohexenyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·14 claims
- 1267US11505550B2ADO-resistant cysteamine analogs and uses thereofHORIZON ORPHAN LLC·Filed 2021·Granted Nov 22, 2022·0 cites·2 claims
- 1358US2023192673A1CompoundsSTEP PHARMA S A S·Filed 2022·Application pending·0 cites
- 1457US12466810B2N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 1552US2024376111A1Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial diseaseMITOKININ INC·Filed 2022·Application pending·0 cites
- 1649US2023020663A1Sulfonamide inhibitors as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1749US2025129080A1Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial diseaseMITOKININ INC·Filed 2022·Application pending·0 cites
- 1848US2023002352A1Sulfonamide derivatives as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1947US2023086703A1N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 2041US2021024507A1CompoundsSTEP PHARMA S A S·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lorna Duffy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →